BLFS Stock Alert: Halper Sadeh LLC is Investigating Whether BioLife Solutions, Inc. is Obtaining a Fair Price for its ShareholdersMorningStar·2 days ago, 04:51 AMBLFS+1.90%RGEN+2.67%
Repligen (RGEN) Dropped, So What Is Behind The Latest Attention?Simplywall·2 days ago, 03:21 AMRGEN+2.67%
Repligen CEO, CFO to join Wells Fargo Healthcare Conference analyst discussionPUBT·Aug 26 at 06:31 AMWFC-0.35%RGEN+2.67%
B. Metzler seel. Sohn & Co. AG Takes $3.60 Million Position in Repligen Corporation $RGENMarket Beat·Aug 22 at 02:20 AMRGEN+2.67%
Repligen CEO Olivier Loeillot disposes of 5,426 common shares worth $976,680PUBT·Aug 21 at 03:07 PMRGEN+2.67%
The Bull Case For Repligen (RGEN) Could Change Following Raised Guidance On Q2 Outperformance - Learn WhySimplywall·Aug 18 at 02:38 PMRGEN+2.67%
Biotech Stocks At 52-Week Highs - OABI, IOVA, PBLS, RVMD, BLFSrttnews·Aug 18 at 06:06 AMPBLS-0.26%RVMD-1.11%
Repligen’s deal for BioLife Solutions indicates shift to manufacturing integrationPharmaceutical Technology·Aug 13 at 05:20 AMBLFS+1.90%RGEN+2.67%
Repligen says BioLife deal targets Q4 close pending regulatory, shareholder approvalsPUBT·Aug 3 at 04:16 PMBLFS+1.90%RGEN+2.67%
Repligen–BioLife Deal: Market, Integration and Regulatory Risks Threaten Growth Outlook and Shareholder ReturnsTip Ranks·Jul 31 at 01:01 AMBLFS+1.90%RGEN+2.67%
13:42 ET$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--LXP, BLFS, PSNL, and FNWDprnewswire·Jul 29 at 12:42 PMFNWD-0.74%BLFS+1.90%
Repligen Corporation Stock 12‑Month Price Target Raised to $177.67, Implies 36% UpsideTradingView·Jul 28 at 03:20 PMRGEN+2.67%
RGEN: Raised 2026 guidance after strong Q2 growth, margin gains, and BioLife acquisition announcementQuartr·Jul 28 at 09:51 AMBLFS+1.90%RGEN+2.67%
